Skip to content

The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Major Depressive Disorder

The Effect of Mediterranean Diet and Mindfulness Eating on Depression Severity in People With Obesity and Major Depressive Disorder - a Randomized Controlled Study With Mulitfactorial Design

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06621394
Acronym
MEDIMIND
Enrollment
64
Registered
2024-10-01
Start date
2024-11-05
Completion date
2025-09-01
Last updated
2025-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depressive Disorder, Major

Keywords

depression, mediterranean diet, mindfulnes eating, nutrition, obesity

Brief summary

The present study investigates the effect of Mediterranean Diet and Mindful Eating on depression severity in people with obesity and major depressive disorder. The factorial design allows to investigate potential synergistic effects of the interventions. Participants will be randomized to one of the four intervention groups (mediterranean diet, mindful eating, their combination and a befriending control group). The intervention consists of a 12-week period, followed by a 12-week follow up. The primary outcome is depression severity.

Detailed description

Depression and obesity are highly prevalent diseases that are strongly correlated. There is a growing gap in care and treatment options for those affected. The effectiveness of a Mediterranean Diet on mental health has already been shown in various studies. Additionally to physiological effects of nutrient intake, also the psychological factor of changing the way of eating seem to play a role. The present study investigates the effect of a Mediterranean Diet and Mindful Eating on depression severity in people with obesity and clinically diagnosed major depressive disorder. The factorial design allows to investigate potential synergistic effects of the interventions. Participants will be randomized to one of the four intervention groups (mediterranean diet, mindful eating, their combination and a befriending control group). The intervention consists of a 12-week period, where five individual nutrition consueling meetings will take place, followed by a 12-week follow up. The primary outcome is depression severity. Secondary outcomes and analyzes include quality of life, self-efficacy, mediterranean diet and mindfulness eating scores, anthropometric measurements, as well as mediator and moderator analysis, a microbiome analysis, a qualitative evaluation and an economic analysis.

Interventions

OTHERnutritional intervention

nutritional intervention to mediterranean diet

BEHAVIORALMindful Eating

intervention regarding mindful eating, e.g. attention while eating, apprechiation of food

OTHERAttention Control

Befreinding Control Group: Provision of same amout of time and attention, without having an intervention, e.g. talking about hobbies and interests, playing card games

Sponsors

Robert Bosch Center for Integrative Medicine and Health
CollaboratorUNKNOWN
Department of Psychosomatic Medicine, Robert Bosch Hospital Stuttgart
CollaboratorUNKNOWN
Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen, University of Tübingen
CollaboratorUNKNOWN
University Hospital Tuebingen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
FACTORIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

data analysis will be conducted blinded

Intervention model description

2x2 factorial design

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Age ≥ 18 years * Presence of clinically diagnosed major depression * At least moderate depression severity: BDI-II ≥ 20 * obesity: BMI ≥ 30 kg/m2 * Stable co-intervention: no change in the type, dosage or frequency of antidepressant medication and/or psychotherapy four weeks before and during the study * Low adherence to the mediterranean diet: MEDAS \< 10 * Low adherence to mindful eating: MEI \< 5.13

Exclusion criteria

* Diseases of the gastrointestinal tract that do not allow adequate implementation of the intervention (e.g. irritable bowel syndrome, post-bariatric surgery, colorectal carcinoma) * Metabolic diseases with strong impact on intervention (e.g. type 1 diabetes mellitus, chronic kidney disease) * Severe food allergies and intolerances, that do not allow adequate implementation of the intervention * Diagnosed, current psychological comorbidities (bipolar disorder, eating disorder, personality disorder, psychosis) * intake of antibiotics in the last three months current substance abuse * Pregnancy and breatfeeding * Suicidal ideation * unable to participate or complete questionnaires Healthy Volunteers: samples of 32 healthy volunteers are included for microbiome analysis only ( inclusion criteria: * age ≥ 18 years * BMI 20 - 30 kg/m\^2

Design outcomes

Primary

MeasureTime frameDescription
Depression severity12 weeksBeck Depression Inventory - II (BDI-II) scores range from 0 to 63 with higher scores indicating higher depression severity

Secondary

MeasureTime frameDescription
Depression severity, self assessment24 weeksBeck Depression Inventory - II (BDI-II) scores range from 0 to 63 with higher scores indicating higher depression severity
Depression Remission Rates12 weeks, 24 weeksrates of participants showing no depressive symptoms, defined as BDI-II less than 9
Quality of Life12 weeks, 24 weeksShort Form-36 Health Survey (SF-36), mental and physical sum score, which can be further divided into the subscales vitality, physical functioning, physical pain, general health perception, physical role function, emotional role function, social role function and psychological well-being, higher scores indicate a higher quality of life
Health status12 weeks,European Quality of Life 5 Dimensions 5 Level (EQ-5D-5L), results in a 5-digit number that describes the patient's health state
Adhernece to Mediterranean Diet12 weeks, 24 weeksmediterranean diet adherence score (MEDAS) scores range from 0 to 14 with higher values indicating higher adherence to mediterranean diet
Adherence to Mindfulnes Eating12 weeks, 24 weeksMindfulness Eating Inventory (MEI), score ranges from 1 to 6, with higher scores indicating higher adherence to mindfulness eating
Depression severity, rater assesment12 weeksDepresion severity is assessed by psychologists by using the MARDS tool. Scores range from 0 to 60 with higher scores idnicating higher severity of depression
Self-efficacy12 weeks, 24 weeksgeneral self-efficacy expectation scale, score ranges from 10 to 40, with a higher score indicating a greater expectation of self-efficacy
Waist to Hip ratio12 weeks, 24 weeksratio of weight circumference and hip circumference
Body composition: muscle mass12 weeks, 24 weeksmuscle mass as a percentage of body weight
Body composition: fat mass12 weeks, 24 weeksfat mass as a percentage of body weight
adverse events12 weeks, 24 weekstime point, duration (in hours or days) and strengths (on a scale from one to ten) of andverse events will be assessed as well as perception of connection between occurrence of adverse event and the intervention
Microbiome Analysis12 weeks16s RNA sequencing
cost-utility analysis12 weeksfrom EQ-5D-5L values quality adjustes life years (QUALYS) will be calulated to conduct cost-utility analysis from participants perspective
Qualitative evaluation12 weeksSemi-structured interviews will consider two areas: 1. the perception on the intervention in terms of feasibility, difficulties in implementation, perception of study setting, planning of long-term implementation, etc. 2. perception of effects of interventions, qualitative evaluation of changes in outcoms, i.e. mood, psychological and physical well-being, self-efficacy, etc
BMI12 weeks, 24 weeksweight and height will be combined to report BMI in kg/m\^2

Countries

Germany

Contacts

Primary ContactAlina Moosburner, MSc
alina.moosburner@med.uni-tuebingen.de+4971181013764
Backup ContactHolger Cramer, Prof. Dr.
holger.cramer@med.uni-tuebingen.de

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026